VK

Vijay Kumar Bijole

Director DIN 03066691
DIN 03066691 First appointment Aug 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijay Kumar Bijole

Data last updated:

Vijay Kumar Bijole was a Director at Safemed Formulation Private Limited (from 2010) and Director at Safecare Medicine Biotech Private Limited (from 2014).

DIN 03066691
First Appointment 30 Aug 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Safemed Formulation Private Limited U85191UR2010PTC033278
Director30 Aug 20102010₹1.2 Lakh (FY 2017)Strike Off
Director24 Nov 20142014₹1,030 (FY 2020)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Safemed Formulation Private Limited
Safecare Medicine Biotech Private Limited
Premium access

Shareholding and investment profile for Vijay Kumar Bijole

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Kumar Bijole

Vijay Kumar Bijole was first appointed on 30 Aug 2010 as Director at Safemed Formulation Private Limited. The most recent appointment on record is 24 Nov 2014 at Safecare Medicine Biotech Private Limited.

Vijay Kumar Bijole held 2 earlier board appointments: Safemed Formulation Private Limited (Director, from 30 Aug 2010); Safecare Medicine Biotech Private Limited (Director, from 24 Nov 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available